Ronald Blue Trust, Inc. Glaukos Corp Transaction History
Ronald Blue Trust, Inc.
- $7.98 Billion
- Q3 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Glaukos Corp stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 57 shares of GKOS stock, worth $8,921. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57
Previous 45
26.67%
Holding current value
$8,921
Previous $5,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding GKOS
# of Institutions
344Shares Held
46.8MCall Options Held
132KPut Options Held
188K-
Black Rock Inc. New York, NY8.04MShares$1.26 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$919 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.18MShares$342 Million0.05% of portfolio
-
State Street Corp Boston, MA1.95MShares$306 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.64MShares$257 Million0.06% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $7.45B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...